首页> 外文期刊>British Journal of Haematology >Immunohistochemical distinction of haematogones from B lymphoblastic leukaemia/lymphoma or B-cell acute lymphoblastic leukaemia (B-ALL) on bone marrow trephine biopsies: a study on 62 patients
【24h】

Immunohistochemical distinction of haematogones from B lymphoblastic leukaemia/lymphoma or B-cell acute lymphoblastic leukaemia (B-ALL) on bone marrow trephine biopsies: a study on 62 patients

机译:B淋巴细胞性白血病/淋巴瘤或B细胞急性淋巴细胞性白血病(B-ALL)血红素对骨髓环蛋白活检的免疫组织化学区分:一项针对62例患者的研究

获取原文
获取原文并翻译 | 示例
           

摘要

Haematogones are normal, maturing B-cell precursors. They can be confused with neoplastic immature lymphoid cells of B lymphoblastic leukaemia/lymphoma or B-cell acute lymphoblastic leukaemia (B-ALL). Though multi-colour flow-cytometry strategies for distinguishing haematogones from cells of B-ALL are well-described, similar strategies have not been determined for bone marrow trephine biopsies (BMTB). We revisited the morphological and immunohistochemical features (CD20, CD34, TdT and PAX5 expression) in 69 BMTB from 62 patients – 27 with excess haematogones; seven with residual B-ALL after therapy; 18 with no reported excess of haematogones or residual acute leukaemia on BMTB; and 17 diagnostic samples of B-ALL. The distinctive immunophenotypic pattern of BMTB with excess haematogones was of CD34, TdT, CD20 and PAX5 accounting for increasing proportions of cells in the order mentioned, whereas among B-ALL, the immunohistochemical pattern was of CD20, PAX5 and TdT accounting for an equal proportion of cells. Furthermore, among haematogones, the intensity of CD20 expression was extremely heterogeneous as compared to the neoplastic cells in CD20-positive B-ALL. The TdT-positive haematogones were generally small and uniform, while a certain degree of heterogeneity was noticed among neoplastic B-ALL cells. This study provides a practical strategy to distinguish haematogones from B-ALL cells in BMTB.
机译:血细胞是正常的,成熟的B细胞前体。它们可能与B淋巴细胞白血病/淋巴瘤或B细胞急性淋巴细胞白血病(B-ALL)的肿瘤性未成熟淋巴样细胞相混淆。尽管已经很好地描述了从B-ALL细胞中区分血红素的多色流式细胞术策略,但尚未确定类似的策略用于骨髓环冰活检(BMTB)。我们重新审查了62例患者中69例BMTB中的形态学和免疫组化特征(CD20,CD34,TdT和PAX5表达),其中27例血红素过多。七个在治疗后残留B-ALL; 18例未报告过BMTB上过量的血原或残留的急性白血病;和17个B-ALL诊断样品。具有过量血红素的BMTB的独特免疫表型模式是CD34,TdT,CD20和PAX5,按提到的顺序占细胞比例的增加,而在B-ALL中,免疫组化模式是CD20,PAX5和TdT,占相同的比例细胞。此外,在血红素中,与CD20阳性B-ALL中的肿瘤细胞相比,CD20表达的强度极为不同。 TdT阳性血细胞通常较小且均匀,而在肿瘤性B-ALL细胞中则观察到一定程度的异质性。这项研究提供了一种从BMTB中的B-ALL细胞中区分血红素的实用策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号